Mirion Technologies is expected to post Q3 2026 revenue of $275.35 million and adjusted EPS of $0.12, with the stock currently trading at approximately $15.15 compared to a consensus price target of $24.48. The primary focus for investors is the company’s ability to drive organic revenue growth through the conversion of its substantial order backlog.
Analysts are looking for a "second-half inflection" characterized by improved volume and margin expansion as nuclear power demand rises. While recent growth has been largely fueled by acquisitions, this report will be a key test of the company's standalone momentum in its Nuclear & Safety and Medical segments.